Healthcare >> CEO Interviews >> October 12, 2001

Remi Barbier – Pain Therapeutics Inc (ptie)

REMI BARBIER is President, CEO and Chairman of Pain Therapeutics, Inc. Prior to PTI, Mr. Barbier helped in the growth or founding of: Exelixis Inc., a functional genomics company; ArQule, a chemistry company; and EnzyMed (now owned by Albany Molecular Research), a chemistry company. Mr. Barbier served as Chief Operating Officer of Exelixis. Prior to that, he was Vice President of Corporate Development and Clinical Project Manager of Xoma Corporation, a biotechnology company. Mr. Barbier received his BA from Oberlin College and his MBA from the University of Chicago. Profile
TWST: What has gone on at Pain Therapeutics since we spoke last?

Mr. Barbier: Before discussing that, perhaps we should remind people

what we do. We develop new and improved painkillers.